Marck Biosciences Ltd, manufacturer and marketer of sterile dosages and Blow-Fill-Seal (BFS) specialist, will soon launch the world's first-ever Paracetamol IV in plastic pack manufactured using BFS technology.

Marck will be contract manufacturing Paracetamol IV and also launch it under its own brand name of ‘Febramol IV' in India as well, Mr Bhavesh Patel, Managing Director, said here.

After three years' efforts, he said, Marck overcame the challenge of developing Paracetamol IV in BFS pack to launch it. The company expects nearly $1 million in sales of this product in the first year of its launch.

The Ahmedabad-based company, which pioneered the export of Paracetamol IV to West Africa, South-East and West Asian markets, will now reach out to the Indian markets.

Marck has received the necessary approvals in Nigeria, Kenya, Benin, Mali, Vietnam and Yemen and is in the process of registering the product in East Africa, CIS and the Latin American countries.

The current size of Paracetamol IV market in India is estimated around 2.5 million bottles a year. Since it is being launched for the first time in India the growth rate is expected to be in excess of 25 per cent every year for the initial three years, said Mr Patel.

SEBI nod for IPO

Marck has also got the SEBI approval to its Draft Red Herring Prospectus for public issue of 1.30 crore equity shares of face value Rs 10 each. It plans to partly utilise the net proceeds of the IPO for setting up a sterile liquid manufacturing plant and expand its operations at an estimated cost of Rs 55 crore, he added.

Related Topics